Corvus Pharmaceuticals, Inc. Share Price

Corvus Pharmaceuticals, Inc. Share Price

NASDAQ: CRVS | Small Cap
$10.25
-$0.29 (-2.71%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Corvus Pharmaceuticals, Inc. Stock Performance

Open
$10.61
Prev. Close
$10.54
Circuit Range
N/A
Day Range
$10.19 - $10.72
Year Range
$6.42 - $26.87
Volume
39,721
Average Traded
$10.35

Corvus Pharmaceuticals, Inc. Share Price Today

As of 30 October 2026, Corvus Pharmaceuticals, Inc.'s share price is $10.25. The stock opened at $10.61, compared to its previous close of $10.54. During today's trading session, Corvus Pharmaceuticals, Inc.'s share price traded between $10.19 and $10.72, with an average price of $10.46. Over the past 52 weeks, the stock has recorded a high of $26.87 and a low of $6.42. In terms of performance, Corvus Pharmaceuticals, Inc.'s share price has declined by 32.48% over the last six months and is up 27.50% on a year-on-year basis.

Corvus Pharmaceuticals, Inc. Share Price Chart

Line chart of the Corvus Pharmaceuticals, Inc. price trend over the selected period. The price fell overall, ranging from 10.17 to 10.72, ending at 10.25.
$10.19$10.72
L
Show Current Price
H

Corvus Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$809.39M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.64
Revenue (TTM)
$0.00
Return On Equity (TTM)
-24.02%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-76.77%

Corvus Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.16-$12.32-$13.69-$17.96
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-21.26%-11.12%-31.19%

Corvus Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$41.31-$27.03-$62.29-$15.28
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A34.57%-130.45%75.47%

About Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Corvus Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$11.47
$10.24
-11.18%
Sep 2026
$14.05
$11.54
-21.66%
Aug 2026
$13.19
$14.72
+11.13%
Jul 2026
$14.90
$13.25
-11.49%
Jun 2026
$12.28
$14.97
+20.43%
May 2026
$15.18
$12.43
-18.12%
Apr 2026
$15.21
$15.18
+3.62%
Mar 2026
$17.78
$14.65
-19.86%
Feb 2026
$20.84
$18.28
-11.61%
Jan 2026
$7.66
$20.68
+169.10%
Dec 2025
$9.00
$7.68
-16.06%
Nov 2025
$7.82
$9.15
+13.88%

CRVS Share Price FAQs